This article is more than 5 years old. Information may no longer be current.
Most popular stories from AAD Summer Meeting
Click Here to Manage Email Alerts
The American Academy of Dermatology Summer Meeting recently wrapped up in New York.
The most popular live coverage from Healio Dermatology spanned JAK inhibitors, various technology disruptions in health care and new therapeutics in the pipeline.
Read on for the most popular hot topics from the meeting.
Systemic therapy with JAK inhibitors may be future of alopecia areata treatment
“I hope I can persuade you that JAK inhibitors for alopecia areata and vitiligo are a really valuable class of medicines,” Brett Andrew King, MD, PhD, FAAD, said. “We don’t yet have one in dermatology, but we will soon. This is really just the beginning.” Read more.
Dermatology is the ‘ subject of massive disruption ’
It is no surprise that dermatology is a “subject of massive disruption but what is surprising is that it is all good,” said health care strategist Nicholas Webb. Read more.
Maintenance therapy vital to acne treatment after antibiotics
Antibiotic stewardship means giving the right antibiotic for the proper duration. Monotherapy is not recommended, and systemic therapy should be limited to 3 months, Jonette Elizabeth Keri, MD, PhD, FAAD, said. Read more.
Therapeutic drugs on the horizon in atopic dermatitis
There are now multiple target treatments to utilize in patients with atopic dermatitis, but there is still a very large unmet need for better treatment in this disease, according to Emma Guttman-Yassky, MD, PhD, a Sol and Clara Kest professor of dermatology at Icahn School of Medicine at Mount Sinai in New York. Read more.